Spyre Therapeutics, Inc. (SYRE) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$39.25
Day's range
$41.88

Spyre Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 11.78 M $594.23 M   1.22% 3.40%
BLACKROCK, INC. 05/13/2026 5.52 M $278.49 M   -0.02% 1.60%
RTW INVESTMENTS, LP 05/15/2026 4.17 M $210.44 M   0.00% 1.21%
FAIRMOUNT FUNDS MANAGEMENT LLC 05/15/2026 4.02 M $202.67 M   0.00% 1.16%
PERCEPTIVE ADVISORS LLC 05/29/2026 3.78 M $190.83 M   23.26% 1.09%
VR ADVISER, LLC 05/15/2026 3.69 M $185.89 M   0.00% 1.07%
05/15/2026 3.06 M $154.22 M   100.00% 0.88%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 2.79 M $140.77 M   -3.18% 0.81%
STATE STREET CORP 05/15/2026 2.61 M $131.50 M   15.21% 0.75%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2026 1.96 M $98.72 M   33.40% 0.57%
COMMODORE CAPITAL LP 05/15/2026 1.91 M $96.46 M   -19.93% 0.55%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 1.90 M $95.87 M   0.00% 0.55%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 1.89 M $95.44 M   0.00% 0.55%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.82 M $92.04 M   17.78% 0.53%
CAPITAL INTERNATIONAL INVESTORS 05/13/2026 1.75 M $88.07 M   -50.00% 0.50%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.72 M $86.82 M   3.72% 0.50%
JANUS HENDERSON GROUP PLC 05/18/2026 1.66 M $83.59 M   -9.45% 0.48%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 1.62 M $81.79 M   0.00% 0.47%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.60 M $80.64 M   -0.20% 0.46%
05/19/2026 1.46 M $73.45 M   0.00% 0.42%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 1.28 M $64.52 M   -10.71% 0.37%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.23 M $61.95 M   192.59% 0.35%
BAKER BROS. ADVISORS LP 05/15/2026 1.00 M $50.44 M   0.00% 0.29%
JPMORGAN CHASE & CO 05/13/2026 979.30 K $44.48 M   1,455.65% 0.28%
BRAIDWELL LP 05/15/2026 932.82 K $47.05 M   -42.93% 0.27%
FRANKLIN RESOURCES INC 05/13/2026 882.83 K $44.53 M   -20.41% 0.26%
CALIGAN PARTNERS LP 05/15/2026 878.13 K $44.29 M   100.00% 0.25%
SIREN, L.L.C. 05/14/2026 818.60 K $41.29 M   0.00% 0.24%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 792.85 K $39.99 M   7.09% 0.23%
UBS GROUP AG 05/05/2026 671.24 K $33.86 M   -1.37% 0.19%
CAPITAL WORLD INVESTORS 05/13/2026 666.56 K $33.62 M   233.00% 0.19%
EMERALD ADVISERS, LLC 05/04/2026 613.37 K $30.94 M   -3.58% 0.18%
CANDRIAM S.C.A. 04/30/2026 610.28 K $30.78 M   43.42% 0.18%
05/08/2026 585.13 K $29.51 M   100.00% 0.17%
NORTHERN TRUST CORP 05/14/2026 578.91 K $29.20 M   3.19% 0.17%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 562.65 K $28.38 M   -2.08% 0.16%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 491.65 K $24.80 M   -46.21% 0.14%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 464.65 K $23.44 M   100.00% 0.13%
EMERALD MUTUAL FUND ADVISERS TRUST 05/04/2026 408.11 K $20.59 M   -1.03% 0.12%
SAMLYN CAPITAL, LLC 05/15/2026 396.66 K $20.01 M   100.00% 0.11%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 338.32 K $17.07 M   893.58% 0.10%
BLACKSTONE INC. 05/15/2026 292.85 K $14.77 M   -41.55% 0.08%
VICTORY CAPITAL MANAGEMENT INC 05/15/2026 292.13 K $14.73 M   99.98% 0.08%
GOLDMAN SACHS GROUP INC 05/15/2026 269.94 K $13.62 M   -1.86% 0.08%
WOODLINE PARTNERS LP 05/15/2026 265.89 K $13.41 M   0.00% 0.08%
MORGAN STANLEY 05/15/2026 246.72 K $12.44 M   35.02% 0.07%
CAPTION MANAGEMENT, LLC 05/15/2026 237.80 K $11.99 M   -40.54% 0.07%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 207.31 K $10.46 M   233.22% 0.06%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 193.03 K $9.74 M   100.00% 0.06%
BANK OF NEW YORK MELLON CORP 05/05/2026 191.40 K $9.65 M   -0.74% 0.06%

Spyre Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 209 institutional investors and hedge funds held shares of Spyre Therapeutics Inc.. The most heavily invested institutionals were:

FMR LLC: 11.78 M

BlackRock, Inc.: 5.52 M

RTW INVESTMENTS, LP: 4.17 M

Fairmount Funds Management LLC: 4.02 M

PERCEPTIVE ADVISORS LLC: 3.78 M

VR Adviser, LLC: 3.69 M

23.88% of Spyre Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 84.92 M shares in the last 24 months. This purchase volume represents approximately $3.49 B in transactions.